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AbSTr AcT
Aims  The aim of our study was to assess the effect of glycemic 
control on placental vascularization in pregnancies compli-
cated by type 1 diabetes mellitus (T1DM) and to compare data-
set of optimal/suboptimal glycemic control to normal placen-
tal 3-dimensional power Doppler (3-DPD) indices in 2nd and 3rd 
trimester.
Methods Placental vascularization of pregnant women was 
prospectively evaluated by 3-DPD ((vascularization-index (VI); 
flow-index (FI); vascularization-flow-index (VFI)) ultrasound 
technique. The normal pregnancies (n = 214) were compared to 
those complicated by T1DM (n = 53) with optimal (HbA1C ≤ 6 %; 
≤ 42 mmol/mol) and suboptimal (HbA1C > 6 %; > 42 mmol/mol) 
glycemic control.
Results Pregnancies complicated by T1DM expressed lower 
placental vascularization indices as compared with normal 
pregnancies (adjusted odds ratio (AOR) for VI:0.86; FI:0.94; 
VFI:0.76). Placental 3-DPD indices have a significant correlation 
with HbA1C and optimal glycemic control is associated with 
lower placental perfusion (AOR for VI:1.64; FI:1.13; VFI:2.34). 
Short-term adverse neonatal outcome was predicted by lower 
3-DPD indices (AORVI:0.83, AORFI:0.93, AORVFI:0.66, p < 0.05 
for each index). Besides the glycemic control, the pregesta-
tional body mass index (BMI), had significant influences on 
placental perfusion.
Conclusions VI displayed the best screening ability for sub-
optimal glycemic control with a sensitivity of 90.9 %. The sub-
optimal glycemic control has a direct deteriorating effect on 
placental vasculature. Therefore the ultrasound examination 
could be an adjunct diagnostic modality for pregnant women 
with T1DM.
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AbbreViATioNS
2-D 2-dimensional
3-D 3-dimensional
3-DPD 3-D power Doppler
AOR adjusted odds ratio
BMI body mass index
BW birth weight
CI confidence interval
DM diabetes mellitus
EF Westimated fetal weight
FI flow index
GA gestational age
HbA1C hemoglobin A1c ←[text has HbA1C]
ICC intra-class correlation coefficient
IUGR intrauterine growth retardation
NICU neonatal intensive care unit
OGTT oral glucose tolerance test
PD Power Doppler
PI pulsatility index
RI resistance index
ROC receiver operating characteristic
S/D ratio  S is the maximum systolic velocity and D 
is the minimum telediastolic velocity
T1DM Type 1 diabetes mellitus
VFI vascularization flow index
VI vascularization index
VOCAL Virtual Organ Computer-aided Analysis
vs versus
Introduction
Type 1 diabetes mellitus (T1DM) complicates approximately 0.3–
0.5 % of pregnancies [1]. Maternal hyperglycemia and elevated 
hemoglobin A1c (HbA1C) are associated with an increased risk of 
adverse perinatal outcome [2–4] and congenital anomalies [5]. The 
glycemic target in T1DM is 6 % (42 mmol/mol) for the HbA1C level 
[6, 7] during pregnancy. Glucose intolerance confers a risk of im-
paired microvasculature, however improved glycemic control re-
duces the risk of unfavourable sequelae [3, 8–10].
Both hyperglycemic spikes and hypoglycemic troughs impair 
endothelial function, and induce oxidative stress and inflammation 
in the placental vascular bed [11, 12]. An altered expression of vas-
oactive and growth factors in the endothelium of villous capillar-
ies and in trophoblasts is a differential response to insulin in T1DM 
[13, 14]. The longitudinal growth of capillaries within a fixed villous 
volume [15–18], the higher branching [19] and increased capillary 
surface and villous volume of the villus relative to capillary volume 
[19] are characteristic features of diabetes mellitus (DM). Howev-
er, Nelson et al. reported no increased vessel density in DM [17].
The augmented blood vessel density in the placental vascular 
bed can be measured by quantifying Doppler signals with 3-dimen-
sional (3-D) scanning technique. 3 small studies report conflicting 
results on the effect of glycemic control on 3-D power Doppler (3-
DPD) indices in diabetic pregnancies [20–22]. Furthermore, there 
is a paucity of data for the effect of glycemic control on the vascu-
lar indices in pregnancies complicated by T1DM in mid- and late 
gestation. Therefore, the aim of this study was to prospectively in-
vestigate alterations of vascular resistence in optimal/suboptimal 
glycemic controlled T1DM pregnancies compared to those indices 
observed in normal gestation during second and third trimester. 
We examined whether placental sonobiopsy could also be useful 
as a complementary diagnostic tool in prognosticating neonatal/
perinatal outcome in T1DM besides the HbA1C.
Subjects, material and methods
Pregnant women at 12 + 0 to 40 + 5 gestational weeks were recruit-
ed for a prospective case-control study at the Department of Ob-
stetrics and Gynaecology, University of Szeged, Szeged, Hungary. 
The T1DM pregnancies (n = 53) were divided into 2 groups: T1DM 
cases with an optimal glycemic control (n = 36, 67.9 %) (HbA1C ≤  
42 mmol/mol,  ≤ 6 %) or cases with suboptimal glycemic control 
(n = 17, 32.1 %) (HbA1C: > 42 mmol/mol, > 6 %). HbA1C was meas-
ured in the first trimester (from 8 to 12 week of gestation) and the 
grouping procedure was based on the American Diabetes Associa-
tion guidelines [6]. The non-pathological control group (n = 214) 
comprised the next 4 consecutive cases without pregestational di-
abetes and with the same maternal characteristics in terms of age, 
gestational age, previous obstetric history and smoking status. All 
pregnancies were dated by first-trimester ultrasound examination.
Obstetric and neonatal complications were recorded prospec-
tively during follow-up. The body mass index (BMI) prior to preg-
nancy (body weight (kg) per height (m²)) was recorded at the ini-
tial visit during prenatal care. Hypertensive disorders defined as 
pregnancy-associated hypertensive disorders (comprising pre-ec-
lampsia or pregnancy-induced hypertension) or essential hyper-
tension were registered. Prematurity was defined as delivery at < 37 
weeks of gestation. Neonatal outcome measurements included 
gestational age, estimated fetal weight (EFW), birth weight (BW), 
preterm delivery, intrauterine growth restriction (more than 2 
standard deviations below the Hungarian growth standard for path-
ologic reasons, < 22 % ), 5 min Apgar score < 7, umbilical cord arte-
rial blood pH < 7.2 and admission to neonatal intensive care unit 
(NICU). Short-term adverse neonatal outcome was classified as at 
least one of the following factors: admission to the NICU, Apgar 
scores < 7 at 5 min, umbilical cord arterial blood pH < 7.2, emergen-
cy caesarean section due to fetal distress.
The study protocol was approved by the Clinical Research Ethics 
Committee of the University of Szeged (Ref. no.:135/2011). The study 
was carried out according to the Principles of the Declaration of 
Helsinki. We obtained written informed consent from all participants.
Exclusion criteria
Exclusion criteria were as follows: multiple pregnancies, enlarged 
( > 3 mm) nuchal translucency between 11 + 0 and 13 + 6 weeks, fetal 
or neonatal structural or genetic anomaly, improper localization of 
the placenta for sonography (placenta praevia, posterior placenta) 
pathological placentation (placenta accreta, increta and percreta), 
self-reported drugs, alcohol, caffeine or nicotine abuse, or expo-
sure to circulatory medication (oxerutins, calcium dobesilate). 
Pregnant women with diabetes accompanied by another systemic 
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disease (e. g., autoimmune disease, vasculitis, hemophylia, throm-
bophylia, HIV infection) were also excluded from the study.
Diagnosis of DM
DM is a pathological condition with previously diagnosed diabetes 
according to the recommendation of the American Diabetes Asso-
ciation [6]. The pregnancy care is supported by diabetologists.
Diagnosis of IUGR
The diagnosis and enrollment of pregnant women affected by IUGR 
was based on estimated fetal weight ( < 10 percentil) after ultra-
sound biometry during routine screening.
Metabolic control
Intensive therapy consisted of insulin administered by either con-
tinuous subcutaneous insulin infusion with an external insulin 
pump or multiple daily insulin injections (3 or more injections per 
day). Insulin therapy was guided by self-monitoring of blood glu-
cose 4 times daily, with additional specified samples, including a 
weekly overnight sample. It also included meticulous attention to 
diet and monthly visits to the treating clinic.
In patients requiring insulin therapy, the ideal frequency of glu-
cose self-monitoring (100 % performed) is the control of the serum 
glucose level before and 1 h after a meal on a daily basis, the month-
ly control of the fructosamine level, the control of the HbA1C level 
every month and the monthly control of the glucose level in urine. 
Glycated hemoglobin, triglyceride values and albuminuria exami-
nation are the main factors considered in the care and therapy of 
diabetic pregnant women [6].
Conventional 2-dimensional (2-D) investigations
The determination of gestational age (GA) and ultrasound biom-
etry (fetal weight estimation and 2-D color Doppler indices [pulsa-
tility indices (PIs) of umbilical and uterine arteries]) were performed 
by conventional methods [20]. The ultrasound investigations were 
conducted by A.S.
Volume acquisition
Acquisition of the images used for the determination of placental 
volume and 3-DPD indices were obtained at the time of the visit. All 
3-D scans were performed by an A.S. Voluson 730 Expert ultrasound 
machine (GE Medical Systems, Kretztechnik GmbH & Co OHG, Aus-
tria) equipped with a multifrequency probe (2–5 MHz) that was used 
to acquire all images. Each sample was examined using the 3-D ren-
dering mode, in which the color and gray value information were 
processed and combined to give a 3-D image (mode cent; smooth: 
4/5; FRQ: low; quality: 16; density: 6; enhance: 16; balance: 150; fil-
ter: 2; actual power: 2 dB; pulse repetition frequency: 0.9) [20]. We 
used fast low resolution acquisition to avoid any kind of artefacts. 
The 3-D static volume box was placed over the highest villous vascu-
lar density zone at the umbilical cord insertion [20]. Each image was 
recovered from the disk in succession for processing. During gesta-
tion we recorded one sample from each patient.
Determination of Power Doppler Indices
The stored volumes were further analyzed using the Virtual Organ 
Computer-aided Analysis (VOCAL) program pertaining to the com-
puter software 4DView (GE Medical Systems, Austria, version 10.4) 
by an expert in 3-D analysis (A.S.). Image used for recovering from 
the hard disk were captured at the time and processed using the 
multiplanar system. The 3 planes of acquired placental volume 
were explored to localize the zone where the highest vascular den-
sity was found by power Doppler mode [23]. The “Mercé-type so-
nobiopsy” is a reproducible and validated method [23–25], and by 
obtaining a representative sample of the placental tree it is appli-
cable throughout the whole pregnancy in contrast to other meth-
ods [20], when the entire placenta needs to be visualized [21, 26]. 
The spherical sample volume was constantly 28 ml. The VOCAL pro-
gram calculated automatically gray and color scale values in a his-
togram from the acquired spherical sample volume in all cases. The 
intraobserver errors were evaluated by repeated measurements of 
the 3-DPD indices at the initiation of the study. The intra-class cor-
relation coefficients for all Doppler indices were excellent (0.99) for 
all indices.
Statistical analysis
Statistical analyses were performed with the SPSS for Windows pro-
gram (SPSS Inc., Chicago, IL, USA). Shapiro-Wilk’s test was used to 
analyze the normal distribution of each variable. Continuous vari-
ables were expressed as median ± interquartile range. Kruskal-Wal-
lis tests were used for comparison of placental 3-DPD indices de-
pending on the 3 groups (T1DM with suboptimal or optimal glyce-
mic control versus (vs.) controls) and to analyze the influence of 
the BMI on the placental 3-DPD indices. Comparisons between the 
2 diabetic subgroups (T1DM with suboptimal or optimal glycemic 
control) were assessed by Mann-Whitney U tests or by χ2 tests for 
continuous and categorical variables, respectively. The association 
between placental 3-DPD indices and 2-D color Doppler indices (PIs 
of umbilical and uterine arteries) and other continuous variables 
were determined by Spearman's rank correlations. The logistic re-
gression models were applied using the maternal vascularization 
index (VI), flow index (FI) and vascularization flow index (VFI) in pre-
dicting suboptimal glycemic control in T1DM pregnancies adjust-
ed for maternal BMI and gestational age as suggested in previous 
studies [24, 27]. Multiple logistic regression coefficient values and 
equations depending on gestational age were also calculated for 
VI, FI, VFI indices both for diabetic and control groups. Receiver op-
erating characteristic (ROC) curve analyses were carried out to as-
sess the global performance of the 3-DPD indices for detecting sub-
optimal glycemic control, as well as to optimise the cut-off points 
for the indices using the trapezoidal rule. A 2-tailed p-value · 0.05 
was considered significant.
Results
No significant differences were observed in the maternal charac-
teristics, obstetric and sonographic data between the T1DM sub-
groups based on the HbA1C concentration. The ultrasound-derived 
EFW did not differ significantly (p = 0.46) between the 2 diabetic 
subgroups.
Pregnancy induced hypertension was not observed, whereas 
pre-eclampsia and essential hypertension were similarly distribut-
ed in the study groups. Regarding the neonatal outcome, subopti-
mal glycemic control was significantly associated with higher birth 
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weight (BW) (p = 0.008) and lower occurrence of intrauterine 
growth retardation (IUGR) (p = 0.03). No other perinatal factors 
were associated with the differences at the level of glycemic con-
trol in T1DM (▶Table 1).
A significant difference could be observed concerning neonatal 
morbidity [n = 41/53 (77 %) vs n = 38/214 (18 %), p = 0.001], but not 
with in respect to perinatal mortality [n = 0/53 (0 %) vs n = 1/214 
(0.5 %), p = 1.0]. A higher prevalence of preterm delivery was re-
corded among the T1DM cases (8/53 = 15.1 %) than in the control 
group (17/214 = 7.9 %) but the difference was not significant. The 
rate of preterm births corresponds well with the Hungarian nation-
al dataset (8.6 % in 2010) [28].
▶Table 2 displays the placental perfusion indices in the 3 study 
groups. VI, FI and VFI values were significantly lower in the T1DM 
group than in the control one. There was a significant reduction 
among diabetic pregnant women with good glycemic control as 
compared to the control group (p < 0.05 for each index). The T1DM 
cases with suboptimal glycemic control had significantly elevated 
placental 3-DPD indices compare to those with good glycemic con-
trol (▶Fig. 1 a-c). Furthermore, the perfusion indices were signifi-
cantly lower in diabetic pregnancies irrespective of glycemic con-
trol compared to those in non-diabetic gestations (p < 0.05 for each 
index) [20].
Multiple logistic regression analysis based on case-control sta-
tus (diabetes vs non-diabetes) showed that the odds of a lower VI 
[p = 0.007, AOR: 0.86 (95 %CI: 0.77–0.96)], a lower FI [p = 0.04, 
AOR: 0.94 (95 %CI: 0.59–0.99)] and a lower VFI [p = 0.023, AOR: 
0.76 (95 %CI: 0.60–0.96)] were detected, where the odds were con-
trolled for BMI and gestational age. The regression equations for 
the prediction of suboptimal glycemic control in T1DM are: 
Y = − 0.335 + 0.494 x VI + 0.107 × BMI − 0.176 × GA, AOR: 1.64, 
p = 0.005; Y = − 4.692 + 0.121 x FI + 0.114 × BMI − 0.114 x GA, AOR: 
1.13,  p = 0.021;  and  Y = − 1.455 + 0.851 × VFI + 0.1174  x 
BMI − 0.127 × GA, AOR: 2.34, p = 0.009; for VI, FI and VFI, respectively.
The HgA1C level correlated significantly with FI (rho:0.498, 
p = 0.025), VI (rho:0.679, p = 0.001) and VFI (rho:0.661, p = 0.001), 
but a different pattern could be observed after controlling for ges-
tational age (FI: rho:0.344, p = 0.274; VFI: rho:0.522, p = 0.082; VI: 
rho:0.026, p = 0.637). Similarly, the associations between BW and 
3-DPD indices were not significant (VI rho = 0.44, p = 0.26; VFI 
rho = 0.31, p = 0.10; FI rho: = 0.16, p = 0.58). Sonographically meas-
ured EFW was not correlated with VI (correlation coefficient 
(rho = 0.47, p = 0.16), VFI (rho = 0.48, p = 0.17) and FI (rho = 0.35, 
p = 0.33) in T1DM. EFW was not a distinguishable factor for good 
glycemic control in relation to placental 3-DPD indices when the 
BMI and gestational age were controlled as cofounders.
T1DM cases were grouped into 3 categories by pregestational ma-
ternal BMI (low: < 19 kg/m2, normal: 19–25 kg/m2, high: > 25 kg/m2). 
BMI was associated with FI (p = 0.032) and VFI (p = 0.066) remarkably, 
especially in underweight cases, while its effect on VI was not signifi-
cant. The modest blood hypertension (from 135/90 Hgmm to 170/ 
100 Hgmm) had no significant distinguishable effect on the 3-DPD 
indices. The efficiency of therapy with insulin pump or convention-
al insulin treatment had no significant effect on the placental 3-DPD 
indices (p > 0.05 for each index). The differences of vascular indices 
between diabetic patients with optimal and suboptimal glycemic 
control or pathologic and non-pathologic pregnancies were unaf-
fected by the manifestation of pre-eclampsia or any type of hyper-
tension, respectively. The short-term adverse neonatal outcome 
was predicted by significantly lower VI (p = 0.027, AOR:0.83), FI 
(p = 0.03, AOR:0.93) and VFI (p = 0.02, AOR:0.66) in T1DM, howev-
er, they were not salient prognosticators in the optimal-subopti-
mal glycemic control relation (p > 0.05 for each index). Similarly, 
fetal sex had a significant effect on the values of vascular indices, 
▶Table 1  Characteristics of control and T1DM group stratified by first trimester HbA1C.
Normal control 
(n = 214)
HbA1c  
levels > 6 % (n = 36) a
HbA1c  
levels  ≤ 6 % (n = 17) b
p value
Maternal age (years) 29.7 [25.4–33.1] 32.0 [31.0–35.0] 31 [29.5–34] 0.393
BMI (kg/m2) 22.6 [19.7–26.1] 24.5 [22.0–31.25] 27 [23.3–32.0] 0.276
Gestational age at ultrasound examination (weeks) 28.7 [17.2–36.6] 29.3 [19.1–32.7] 30.1 [24.5–35.9] 0.365
Gestational age at delivery (weeks) 38.2 [37.2–40.4] 38.2 [36.56–38.7] 37.0 [36.1–38.0] 0.523
Estimated fetal weight at ultrasound examination (grams) 1297 [701.3–1390.1] 1735 [789.5–2434.8] 1325.5 [736.5–1869.8] 0.46
Essential hypertension (n, %) 0 0 0 0 1 5.9 0.32
Pre-eclampsia(n, %) 0 0 5 13.9 1 5.9 0.65
Hypertensive disorders (n, %) 0 0 5 13.9 2 11.8 1.00
Prematurity (n,  %) 3 1.4 3 8.3 5 29.4 0.09
Intrauterine growth retardation (n, %) 0 0 1 2.8 4 23.5 0.03
Birthweight (grams) 3139 [2980–3750] 4210 [3770–4650] 3480 [3080–3670] 0.008
5 min Apgar score < 7 (n,  %) 0 0 0 0 0 0 –
Umbilical cord pH < 7.2 (n,  %) 0 0 0 0 0 0 –
NICUc admission (n,  %) 2 0.9 0 0 2 11.8 0.099
Short-term adverse perinatal outcomed (n,  %) 16 7.4 1 2.8 3 17.6 0.092
male gender (n,  %) 126 58.8 19 52.7 11 64.7
a Type 1 diabetes mellitus with suboptimal glycemic control (HbA1C was measured from 8–12 weeks of gestation); b Type 1 diabetes mellitus with 
optimal glycemic control (HbA1C was measured from 8–12 weeks of gestation); c NICU: Neonatal intensive care unit; d Short-term adverse neonatal 
outcome was defined as at least one of the following factors: admission to the NICU, Apgar scores < 7 at 5 min, umbilical cord pH < 7.2, emergency 
caesarean section. Data are displayed as median ± interquartile range and n ( %).
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VI, FI or VFI in the case-control context (p = 0.03, p = 0.03, p = 0.02, 
respectively), but not in the optimal-suboptimal glycemic control 
relation (p > 0.05 for each index). Generally, pregnancies with a 
male infant had a trend of lower indices.
▶Fig. 2a-c illustrates the screening attributes of 3-DPD indices 
for suboptimal glycemic control in T1DM. The best parameter for 
predicting suboptimal glycemic control in T1DM pregnancies was 
VI, while VFI and FI also showed satisfactory screening capacity. The 
cut-off value for suboptimal glycemic control was VI = 3.3 (specific-
ity: 77.8 and sensitivity: 90.9), FI = 1.2 (specificity: 77.7 and sensitiv-
ity: 81.8) and VFI = 37 (specificity: 88.9, sensitivity: 72.7). Regarding 
the screening properties, the detection rates and false positive rates 
for poor glycemic control using VI were 90 % and 22 %, respectively.
With regard to the 2-D color Doppler indices (PIs and resistance 
indices (RI) of umbilical and uterine arteries), FI correlated well with 
the uterine artery PI (rho:  − 0,714; p = 0.047) in pregnancies com-
plicated by T1DM. In cases with good glycaemic control, VI 
(rho:  − 0,820; p = 0.002) and VFI (rho:  − 0.787; p = 0.004) correlat-
ed negatively with RI of the uterine artery, whereas the poor glyce-
mic control did not exert any significant effect on the correlation 
between 3-D placental and 2-D uteroplacental indices.
Discussion
The principal finding of the study is the declining tendency of 
3-DPD indices in T1DM cases with an optimal glycemic control or 
a suboptimal glycemic control as gestation advances. This contrast 
non-pathologic pregnancies [20], in which the indices are statisti-
cally invariant thought pregnancy. In type 1 diabetes, the placen-
tal vascular alteration is related to maternal glucose metabolic dis-
turbance, since suboptimal glycemic control is significantly associ-
ated with higher placental vascularisation indices. The HbA1C level 
expresses a positive correlation with VI and VFI, however its effect 
on the FI is more modest. However, the VI, FI, VFI values of the con-
trol and diabetic groups overlap; hence, the 3-DPD indices have 
only complementary modality for glycemic control screening. This 
might be explained by the fact that even mild gestational hyper-
glycemia results in increased numbers of terminal villi and capillar-
ies indicating deregulated, non-controlled angiogenic signals in 
the placenta during diabetes [29].
One of our most striking results is that the lower vascularization 
values predict the adverse neonatal outcome in T1DM which might 
be explained by the fact that decreased placental perfusion is re-
▶Table 2 Placental 3-dimensional power Doppler indices of the study groups.
T1DM (HbA1c 
levels > 6 %) (n = 36)a
T1DM (HbA1c 
levels  ≤ 6 %) (n = 17)b
p-value c Matched normal 
controls (n = 215)
p-value d
Vascularization index (mean ± S.D.) 7.10 [4.80–9.0] 2.5 [1.0–4.7] 0.018 9.1 [5.2–13.3]  < 0.001
Flow index (mean ± S.D.) 47.7 [36.0–51.0] 33.1 [28.8–36.7] 0.037 44.9 [39.1–51.3] 0.002
Vascularization flow index (mean ± S.D.) 3.4 [2.1–4.7] 0.77 [0.3–1.7] 0.016 4.2 [2.2–6.3] 0.001
a Type 1 diabetes mellitus with optimal glycemic control (HbA1C was measured from 8 to 12 weeks of gestation); b Type 1 diabetes mellitus with 
suboptimal glycemic control (HbA1C was measured from 8 to 12 weeks of gestation); c Mann-Whitney U-tests between the 2 diabetic groups showed 
the presented p-values. Multiple logistic regression controlled for gestational age showed a p-value of 0.007 for Vascularization index, 0.04 for Flow 
index, and 0.023 for Vascularization flow index; d p-values by the Kruskal-Wallis tests on all 3 groups are presented. Mann-Whitney U-probes of the 
placental indices of controls and T1DM pregnancies with suboptimal glycemic controls have not demonstrated any significant differences in any of 
the placental indices; Data are displayed as median ± interquartile range.
▶Fig. 1 The placental 3-D power Doppler indices illustrated by 
gestational age in the study groups a vascularization index b flow 
index c vascularization flow index.
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lated to decreased stress tolerance of the fetus during delivery. 
Male fetuses have more likely lower placental perfusion indices that 
can be related to the fact that male infants and their placentas tend 
to be larger, but our results not support that fact.
The quantitative sonographic changes in the placental vascular 
tree in pregnancies complicated by T1DM with poor or good gly-
cemic control are not well defined. Gonzalez et al. [22] reported 
significantly lower placental vascular indices in the first trimester 
in a pregnant women with pregestational DM, which was not af-
fected by glycemic control. Similarly, we have found reduced flow 
indices in an assortment of diabetic pregnancies in a later gesta-
tional period compared to controls in a previous study [20]. Rizzo 
et al. [21] suggested an increased circulation in diabetic placentas 
with poor glycemic control from the 11th week until the end of the 
13th week of gestation compared to those with good glycemic con-
trol. Both studies reported by others [21, 22] applied flowmetry of 
the entire placenta in the first trimester that cannot be used dur-
ing mid- and late-pregnancy. On the contrary, we utilized “Mercé 
type sonobiopsy” [24] in this study, because this flowmetry meth-
od does not require that the entire placenta is in the sonographic 
view, which is impossible in the later gestation. Although, the flow 
“biopsy” was extracted from a spot at the umbilical cord insertion 
as the best vascularized place of the placenta. This is a valid meth-
od with a low intra- and interobserver error [20].
The dependency of the 3D vascular indices on gestational age 
are non-significantly virtually unchanged throughout non-patho-
logical gestation as expressed by equation trendlines of linear re-
gression [20]. The underlying histological processes are the follow-
ing: the teminal villi are smaller with a scant stroma in an incon-
spicuous, discontinuous cytotrophoblast layer by the end of 
gestation. Mature intermediate villi lose their reticular stroma and 
become smaller in diameter [30].
The placenta in diabetes is characterized by increased surface 
area, thickening of the trophoblast basement membrane, increased 
number of cytotrophoblasts as well as increased number and ca-
liber of blood vessels. [29]. Our present study supports this ten-
dency in a later phase of gestation as well and the trendlines of the 
3-DPD indices are exponential during gestation.
In T1DM, > 50 % of placental microvessels showed complete im-
pairment and actually the loss of arterioles could be established 
[29, 30]. These pathohistological processes in diabetic groups could 
be detected via diminished 3-DPD indices as compared to the con-
trol group [20]. In pregnancies complicated by DM, de novo syn-
thesis of blood vessels in placenta occurs already in the first trimes-
ter [21, 32]. Moreover, the diabetic milieu induces an early vascular 
maturation and functioning already in the first trimester, and a final 
burst of angiogenesis in the third trimester [29]. A higher density 
of chorionic villous material exhibits a higher flow resistance and 
hence lower maternal blood perfusion [29, 33, 34]. This is reflect-
ed by our results.
Another important result was that EFW can be linked to lower 
3-DPD indices in affected cases. This connection is appropriate not 
only for EFW, but also for BW. The large infant weight is often at-
tributed to the maternal diabetes control and the related altered 
placental vasculature [31]. An EFW of > 90th centile occurs in 
20–25 % of infants of women with insulin-dependent diabetes 
[35, 36]. In our cases it was 14/53 (26.4 %).
Moreover, in pregnancies complicated by diabetes, and particu-
larly those involving vascular disease, impairment of placental per-
fusion will typically lead to asymmetric or disproportional growth 
retardation of the fetus (Reece 1998). Our cases have IUGR in 5/53 
(9.4 %). Any insult of the diabetic environment early in pregnancy 
will alter the placenta in a period critical for later development and, 
hence, have long term effects on placental function and structure 
[29]. The tendency of women to develop hypertension during these 
pregnancies appears to be a result of the maternal response to im-
prove placental perfusion [22, 37, 38], based on 2-D Doppler stud-
ies. Yet we observed that hypertension as a complication in T1DM 
has a diminishing effect on FI, and the increased blood pressure 
leaves the VI and VFI unaffected.
Our results suggest that underweight BMI may be primarily re-
sponsible for changes in placental VI, more characteristically, than 
▶Fig. 2 a Receiver operating characteristic curve for predicting poor glycemic control using VI. Area under curve: 0.81, specificity: 77.8, sensitivity: 
90.9. b Receiver operating characteristic curve for predicting poor glycemic control using FI. Area under curve: 0.81, specificity: 77.7, sensitivity: 
81.8. c Receiver operating characteristic curve for predicting poor glycemic control using VFI. Area under curve: 0.77, specificity: 88.9, sensitivity: 72.7.
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BMI excess. Our study ascertains, that there is a strong association 
between the lower and higher BMI and lower 3-DPD placental in-
dices and with glycated hemoglobin levels. Consequently, the preg-
nancy care of the diabetic pregnant women should strive to attain 
not only excellent glycemic control, but also an effective control of 
BMI to normal levels.
It is notable, however, that maternal T1DM and indeed mater-
nal HbA1C are related to most of the placental stereological pa-
rameters [15–19]. This would suggest that excess maternal nutri-
ent supply may be primarily responsible for changes in develop-
ment of placental vascularization, and, where present, such 
changes and decreases in placental vascularization, increases in 
placental weight in general follow increased fetal weight. Increas-
es in capillary volume and surface area [15], villous immaturity, vil-
lous surface area [16], increased total diffusive conductance, and 
intervillous and trophoblast volume [29] were described and their 
presence or absence often ascribed to the degree of maternal dia-
betes control [18, 19].
Conventional 2-D Doppler studies (umbilical and uterinal arter-
ies) are ineffective for distinguishing fetuses of diabetic pregnant 
women from non-pathological individuals, as it was is manifested 
in our previous results [20].
We recommend that monitoring of 3-DPD sonographic vascu-
lar indices should be introduced in the pregnancy care of T1DM in 
the second and third trimester as a complementary modality to 
glycemic control, because the decreasing vascular indices may 
prognosticate an adverse neonatal outcome. Further studies with 
larger sample size and other sonographic techniques are required 
to analyze placental perfusion in T1DM.
■■■Quick summary
The 3-DPD sonographic vascular indices should be introduced 
in the pregnancy care of T1DM during second and third trimester 
as a complementary modality to glycemic control, beside HbA1C, 
because the decreasing vascular indices are responding to chang-
es more quickly to predict the risk of adverse perinatal out-
come.■■■
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one sentence summary: The 3-DPD vascular indices should be in-
troduced in the pregnancy care of T1DM during later pregnancy as 
a complementary modality to glycemic control, beside HbA1C, be-
cause the decreasing vascular indices are responding to changes 
more quickly to predict the risk of adverse perinatal outcome.
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